These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3323104)

  • 21. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 22. Dysregulation of the calcium, phosphorus, parathyroid hormone, and vitamin D axis: what are the causes and risks?
    Bushinsky DA
    Am J Kidney Dis; 2001 Jun; 37(6):1310-2. PubMed ID: 11382706
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parathormone and calcitonin in the blood in chronic kidney diseases].
    Mosin VM; Iagoda AV; Salanda BS; Derevianko NA
    Ter Arkh; 1982; 54(7):82-4. PubMed ID: 7135230
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin D metabolite requirements in dialysed children receiving recombinant human growth hormone.
    Pańczyk-Tomaszewska M; Ziółkowska H; Debiński A; Sieniawska M
    Nephrol Dial Transplant; 2000 Mar; 15(3):375-8. PubMed ID: 10692523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D compounds for people with chronic kidney disease requiring dialysis.
    Palmer SC; McGregor DO; Craig JC; Elder G; Macaskill P; Strippoli GF
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005633. PubMed ID: 19821349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
    Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
    Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal osteodystrophy in CAPD patients.
    Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
    Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
    Zehnder D; Landray MJ; Wheeler DC; Fraser W; Blackwell L; Nuttall S; Hughes SV; Townend J; Ferro C; Baigent C; Hewison M
    Nephron Clin Pract; 2007; 107(3):c109-16. PubMed ID: 17890873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biochemical changes with continuous ambulant peritoneal dialysis (CAPD)].
    Fuchs C; Armstrong VW; Dorn D; Ebert R; Scheler F
    Z Urol Nephrol; 1982 Jun; 75(6):415-27. PubMed ID: 6750973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin.
    Body JJ; Cryer PE; Offord KP; Heath H
    J Clin Invest; 1983 Mar; 71(3):572-8. PubMed ID: 6402521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J; Saracho R; González O; Moina I; Martínez I
    Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phosphorus and calcium metabolism and its hormonal regulation in chronic kidney failure].
    Nikiforova NV; Strunin SE; Ermolenko VM; Mozzhechkov VT; Khomiakova VN
    Ter Arkh; 1985; 57(1):103-7. PubMed ID: 3983831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low-level lifetime exposure to cadmium on calciotropic hormones in aged female rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Arch Toxicol; 2005 Nov; 79(11):636-46. PubMed ID: 15940469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
    Rouached M; El Kadiri Boutchich S; Al Rifai AM; Garabédian M; Fournier A
    Kidney Int; 2008 Aug; 74(3):389-90. PubMed ID: 18626497
    [No Abstract]   [Full Text] [Related]  

  • 39. Control of mineral metabolism in CAPD patients.
    Delmez JA
    Blood Purif; 1989; 7(2-3):167-80. PubMed ID: 2663036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
    Messa P; Mioni G; Turrin D; Guerra UP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.